Back to Results
First PageMeta Content
Medicine / Wellness / Biosimilar / Patient Protection and Affordable Care Act / Biologic / Food and Drug Administration / Pharmacology / Clinical research / Pharmaceutical sciences


Benefit Briefs Brought to you by System Benefits Administration Issue #47, May 2015
Add to Reading List

Document Date: 2015-05-05 17:46:43

Open Document

File Size: 158,09 KB

Share Result on Facebook

Company

TIAA-CREF / The Express / Sanford C. Bernstein & Company / Amgen / BlueCross BlueShield of Texas / Advised Assets Group LLC / EyeMed / Express Scripts / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

desktop site / cancer care / chemicals / /

MedicalCondition

cancers / cancer / older cancer / diabetes / infections / breakthrough cancer / autoimmune diseases / /

MedicalTreatment

chemotherapy / /

Organization

Food and Drug Administration / System Employee Benefits Advisory Committee / FDA / Texas A&M University / American Diabetes Association / /

Person

Ronny Gal / Catapult / /

Position

personal physician / physician / manager of prescription drug benefits / senior research analyst / registered investment adviser / /

Product

Herceptin / Enbrel / Neupogen / Zarxio / Remicade / Avastin / Biosimilar Drug / /

ProvinceOrState

Texas / /

Technology

chemotherapy / mobile device / /

URL

www.texasaver.com / http /

SocialTag